Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10201 - 10225 of 10303 in total
Lintitript is a new, highly specific and potent CCK-A receptor antagonist.
Investigational
Investigational
ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.
Investigational
Investigational
Liothyronine I-131 has been used in trials studying the treatment of Tricuspid Atresia and Heart Defects, Congenital.
Investigational
Displaying drugs 10201 - 10225 of 10303 in total